NITAG Support Hub (NISH) Webinar Series
Applying Vaccine Prioritization Strategies for Optimized Public Health Outcomes
This webinar series, of five sessions, is designed to strengthen the capacity of NITAGs and their secretariats in the areas of New Vaccine Introduction Prioritization and Vaccine Program Optimization (VPOP). The series will run from October 2025 and aims to:
- Provide a structured learning pathway on prioritization and optimization concepts.
- Introduce and demonstrate the use of the NVI-PST Tool to support evidence-informed recommendations.
- Facilitate peer-to-peer exchange and sharing of lessons learned across the region.
- Support countries in adapting prioritization and optimization approaches to their context.
Help Us Support Your NITAG
We would appreciate your NITAG (at least two members/member and Chair) completing the Baseline support survey to let us know your country NITAG needs. This will be critical to help us plan for how NISH and partners may provide the best support after the webinar training ends in January.
You can meet with your NITAG to do this at your convenience and submit a response (you may also resubmit another response with more inputs later, if more NITAG members become available).
Session 3: NVI-PST Tool: Defining Criteria
Purpose / Key Topics:
- Equip NITAGs to define and adapt prioritization criteria that are context-appropriate.
- Aligned vaccinology topic.
- Collecting country preferences on vaccines and criteria to be used.
- Discussing vaccine and criteria.
- Collecting and summarize evidence for NITAG Recommendations and Sequencing.
Recording and Slide Deck
Session Recording (English)
Session Recording (French)
Downloadable Resources
Slide Deck 1 (PDF): Download Presentation Slides 1 (English)
Slide Deck 2 (PDF): Download Presentation Slides 1 (English)
Slide Deck 1 (PDF): Télécharger les diapositives de présentation (French)
Slide Deck 2 (PDF): Télécharger les diapositives de présentation (French)
Article to Read: Prioritization of future new vaccines introduction
We value your feedback! Please take a moment to complete our survey:
Registration and Language Details
English Session
🗓️ Date: 19 November 2025
🕒 Time: 12:00–13:30 South Africa Standard Time (SAST; GMT+2)
🎙️ Format: 90-minute live webinar
💻 Platform: Zoom (Register Here)
French Session
🗓️ Date: 20 November 2025
🕒 Time (TBC):12:00–13:30 South Africa Standard Time (SAST; GMT+2)
🎙️ Format: 90-minute live webinar
💻 Platform: Zoom (Register Here)
The equivalent times in different time zones in Africa can be converted using this link: World Clock Converter.
Session 3 Program
| Time | Presentation | Presenter(s) |
|---|---|---|
| 5 min | Welcome & recap from Session 2 | Louise Henaff, WHO HQ |
| 15 min | Searching for Evidence relevant to decision-making | Dilshaad Brey, NISH |
| 15 min | Collecting country preferences on vaccines & criteria | Kamel Senouci, Development Catalysts |
| 15 min | Country experiences and Interactive discussion: adapting criteria to local context | Tewodros Alemayu JSI (Ethiopia) and NITAG Chair Uganda, Deogratias Munube |
| 15 min | Collecting & summarizing evidence for NITAG recommendations | Kamel Senouci, Development Catalysts |
| 20 min | Country Experiences and Interactive discussion: Collecting and synthesising evidence | Deogratias Munube, NITAG Uganda |
| 5 min | Closing remarks | Lora Shimp, JSI |
Other Sessions in this Series
Session 1
Overview of NVI Prioritization
Build a shared understanding of prioritization and optimization concepts and clarify the NITAG’s role.
Session 2
Introduction to NVI-PST Tool
Familiarize participants with the NVI-PST and how its objectives, methodology, and toolkit complement existing decision-support tools (EtR).
Session 4
NVI Prioritization: Application
Enable practical application of the tool through discussions on importance, feasibility, sequencing, and lessons learned from other countries.
Session 5
Deep Dive: Program Optimization
Strengthen the ability to assess when and how optimization should occur, including shared definitions and review of possible vaccine switches.